Westhampton Capital’s Dentsply Sirona XRAY Stock Holding History

Westhampton Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,680	Closed	-$467K	–	122
2023 Q3	$467K	Hold	13,680	–	–	0.3%	83
2023 Q2	$547K	Hold	13,680	–	–	0.36%	72
2023 Q1	$537K	Hold	13,680	–	–	0.35%	81
2022 Q4	$436K	Hold	13,680	–	–	0.29%	86
2022 Q3	$388K	Sell	13,680 -125	-0.9%	-$4.27K	0.29%	89
2022 Q2	$493K	Sell	13,805 -100	-0.7%	-$4.04K	0.35%	81
2022 Q1	$684K	Hold	13,905	–	–	0.44%	69
2021 Q4	$776K	Hold	13,905	–	–	0.47%	66
2021 Q3	$807K	Sell	13,905 -550	-4%	-$33.9K	0.55%	57
2021 Q2	$914K	Hold	14,455	–	–	0.59%	55
2021 Q1	$922K	Hold	14,455	–	–	0.64%	51
2020 Q4	$757K	Sell	14,455 -775	-5%	-$38.2K	0.56%	54
2020 Q3	$666K	Sell	15,230 -75	-0.5%	-$3.32K	0.54%	53
2020 Q2	$674K	Hold	15,305	–	–	0.59%	51
2020 Q1	$594K	Buy	15,305 +400	+3%	+$20.4K	0.62%	49
2019 Q4	$843K	Sell	14,905 -2,000	-12%	-$112K	0.68%	45
2019 Q3	$901K	Hold	16,905	–	–	0.75%	39
2019 Q2	$987K	Buy	+16,905	New	+$908K	0.83%	38

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Westhampton Capital's XRAY Position: Q4 2023 in Review

Westhampton Capital sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 13,680 shares — an estimated $467K sold.

Westhampton Capital first reported a position in XRAY in Q2 2019 and held it in 18 quarters. The position peaked at $987K in Q2 2019. 416 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

Westhampton Capital reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
Westhampton Capital sold 13,680 Dentsply Sirona shares in Q4 2023, an estimated $467K.
Westhampton Capital first reported a position in Dentsply Sirona in Q2 2019 and held it in 18 quarters.
Westhampton Capital's Dentsply Sirona position peaked at $987K in Q2 2019.
416 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on Westhampton Capital's 13F filing for Q4 2023, filed 19 Jan 2024.